Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myeloproliferative disorders.

H S Gilbert

    Clinics in Geriatric Medicine
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Myeloproliferative disorders involve abnormal blood cell growth. Understanding their complex nature is key to managing complications and improving patient survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.

    Oncology (Williston Park, N.Y.)·2001
    Same author

    Current management in polycythemia vera.

    Seminars in hematology·2001
    Same author

    Familial myeloproliferative disease.

    Bailliere's clinical haematology·2000
    Same author

    Historical perspective on the treatment of essential thrombocythemia and polycythemia vera.

    Seminars in hematology·1999
    Same author

    Long term treatment of myeloproliferative disease with interferon-alpha-2b: feasibility and efficacy.

    Cancer·1998
    Same author

    Rupture of abdominal aortic aneurysm demonstrated on Tc-99m RBC gastrointestinal bleeding study.

    Clinical nuclear medicine·1995
    Same journal

    Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

    Clinics in geriatric medicine·2026
    Same journal

    Preventive Cardiology for the Clinically Complex Older Adult.

    Clinics in geriatric medicine·2026
    Same journal

    A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

    Clinics in geriatric medicine·2026
    Same journal

    Secondary Prevention in Older Adults: Putting It All Together.

    Clinics in geriatric medicine·2026
    Same journal

    Primary Prevention in Older Adults: Putting It All Together.

    Clinics in geriatric medicine·2026
    Same journal

    Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

    Clinics in geriatric medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Internal Medicine

    Background:

    • Myeloproliferative disorders (MPDs) arise from the monoclonal proliferation of hematopoietic stem cells.
    • These disorders are characterized by variable phenotypic expression, ranging from hyperplasia to malignancy.
    • MPDs commonly affect the geriatric population and present diagnostic and management challenges due to their chronic and heterogeneous nature.

    Purpose of the Study:

    • To elucidate the pathophysiology of myeloproliferative disorders.
    • To highlight the diagnostic and management challenges associated with MPDs.
    • To emphasize the need for individualized treatment strategies to optimize patient outcomes.

    Main Methods:

    • Review of the pathophysiology of MPDs, including cellular proliferation and differentiation.

    Related Experiment Videos

  • Analysis of clinical manifestations, including hyperplastic bone marrow, extramedullary hematopoiesis, and secondary fibrosis.
  • Examination of common complications such as thrombosis, hemorrhage, anemia, and hypersplenism.

    • Main Results:

    • MPDs result in increased circulating erythrocytes and platelets, bone marrow changes, and extramedullary hematopoiesis.
    • These alterations lead to significant complications including thrombosis, hemorrhage, splenic infarction, hypersplenism, and anemia.
    • The variability in disease presentation and chronicity complicate diagnosis and treatment.

    Conclusions:

    • Individualized treatment approaches are essential for managing MPDs.
    • A thorough understanding of MPD pathophysiology is crucial for effective complication management.
    • Optimizing complication-free survival requires balancing disease risks, therapeutic risks, and supportive care.